Use of egf to inhibit pathogenic infections of the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61P 13/00 (2006.01) A61P 15/00 (2006.01)

Patent

CA 2464609

This invention relates to treating or preventing pathogenic infections with an epidermal growth factor (EGF). EGF is capable of inhibiting pathogenic colonization of pathogens in a variety of tissue or cell types. Since pathogenic colonization is essential for pathogenic infection, EGF can be used as an effective preventive and therapeutic agent for pathogenic infections, particularly in the urogenital tract.

La présente invention concerne le traitement et la prévention d'infections pathogènes à l'aide d'un facteur de croissance épidermique (EGF). L'EGF peut inhiber la colonisation pathogène de pathogènes dans une variété de types de tissus ou de cellules. Etant donné que la colonisation pathogène est essentielle pour l'infection pathogène, l'EGF peut être utilisé en tant qu'agent prophylactique et thérapeutique efficace contre les infections pathogènes, notamment au niveau du tractus urogénital.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of egf to inhibit pathogenic infections of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of egf to inhibit pathogenic infections of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of egf to inhibit pathogenic infections of the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1904997

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.